Showing results (11-20 of 76) with videos related to
Sort By:
Pageof 8
Cells|October 28, 2025
The Evolution, Current Landscape, and Future Prospects of Oncolytic Virotherapy in Melanoma: Talimogene Laherparepvec and BeyondJohn Smestad, John Rieth, Douglas Laux, et al.BMJ Case Reports|August 27, 2021
Sustained response to imatinib in patient with extraskeletal myxoid chondrosarcoma and novel KIT mutationBrooke Jennings, John Rieth, Travis Snyders, et al.Case Reports in Oncological Medicine|April 10, 2019
Clinical Challenges with Talimogene Laherparepvec: Cured Lymph Nodes Masquerading as Active MelanomaUmang Swami, Brian Swick, Yousef Zakharia, et al.Critical Reviews in Oncology/Hematology|January 22, 2019
Advanced stage melanoma therapies: Detailing the present and exploring the futureChelsea Luther, Umang Swami, Jun Zhang, et al.Clinical Nuclear Medicine|December 11, 2025
Vascular Leiomyosarcoma Masquerading as Chronic Deep Venous ThrombosisIsabella Phillips, Jason Chen, Mohammed Milhem, et al.Journal of Oncology|August 21, 2019
Durable Clinical Benefit in Patients with Advanced Cutaneous Melanoma after Discontinuation of Anti-PD-1 Therapies Due to Immune-Related Adverse EventsUmang Swami, Varun Monga, Aaron D Bossler, et al.Melanoma Research|August 8, 2018
Toxicities with targeted therapies after immunotherapy in metastatic melanomaNicole Grogan, Umang Swami, Aaron D Bossler, et al.Molecular & Cellular Proteomics : MCP|December 16, 2017
Insights into the Proteome of Gastrointestinal Stromal Tumors-Derived Exosomes Reveals New Potential Diagnostic BiomarkersSafinur Atay, Daniel W Wilkey, Mohammed Milhem, et al.Cancers|December 11, 2019
Efficacy and Adverse Events in Metastatic Melanoma Patients Treated with Combination BRAF Plus MEK Inhibitors Versus BRAF Inhibitors: A Systematic ReviewAustin Greco, Danish Safi, Umang Swami, et al.Annals of Translational Medicine|July 19, 2021
Current status of intralesional agents in treatment of malignant melanomaMisam Zawit, Umang Swami, Hassan Awada, et al.Pageof 8